Education
About Us
Working with TipRanks
Follow Us
Mustang Bio Inc (MBIO)
NASDAQ:MBIO
MBIO Stock Chart & Stats
$1.09
-$0.01(-4.59%)
At close: 4:00 PM EST
$1.09
-$0.01(-4.59%)
Day’s Range― - ―
52-Week Range$0.89 - $21.99
Previous CloseN/A
Volume2.68M
Average Volume (3M)94.14K
Market Cap
$7.96M
Enterprise Value-$10.65M
Total Cash (Recent Filing)$18.98M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.16
Next Earnings
May 09, 2025EPS Estimate
-5.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-43.66
Shares Outstanding6,453,701
10 Day Avg. Volume88,215
30 Day Avg. Volume94,141
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)-14.00
Price to Sales (P/S)0.00
P/FCF Ratio-4.75
Enterprise Value/Market Cap-1.34
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit259.87
Enterprise Value/Ebitda4.55
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-17.5
Revenue Forecast (FY)N/A
Mustang Bio News
MBIO FAQ
What was Mustang Bio Inc’s price range in the past 12 months?
Mustang Bio Inc lowest stock price was $0.89 and its highest was $21.99 in the past 12 months.
What is Mustang Bio Inc’s market cap?
Mustang Bio Inc’s market cap is $7.96M.
When is Mustang Bio Inc’s upcoming earnings report date?
Mustang Bio Inc’s upcoming earnings report date is May 09, 2025 which is 227 days ago.
How were Mustang Bio Inc’s earnings last quarter?
Mustang Bio Inc released its earnings results on Mar 24, 2025. The company reported -$0.95 earnings per share for the quarter, beating the consensus estimate of -$5.5 by $4.55.
Is Mustang Bio Inc overvalued?
According to Wall Street analysts Mustang Bio Inc’s price is currently Overvalued.
Does Mustang Bio Inc pay dividends?
Mustang Bio Inc does not currently pay dividends.
What is Mustang Bio Inc’s EPS estimate?
Mustang Bio Inc’s EPS estimate is -5.5.
How many shares outstanding does Mustang Bio Inc have?
Mustang Bio Inc has 6,453,701 shares outstanding.
What happened to Mustang Bio Inc’s price movement after its last earnings report?
Mustang Bio Inc reported an EPS of -$0.95 in its last earnings report, beating expectations of -$5.5. Following the earnings report the stock price went down -1.695%.
Which hedge fund is a major shareholder of Mustang Bio Inc?
Currently, no hedge funds are holding shares in MBIO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mustang Bio Inc
Mustang Bio, Inc. (MBIO) is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for the treatment of cancer and rare genetic diseases. The company's primary focus lies in advancing its gene and cell therapy platforms, which are designed to harness the power of the patient's immune system to target and eliminate diseased cells. Mustang Bio is involved in both clinical and preclinical development stages, working on a pipeline of promising therapeutic candidates.
Technical Analysis
XTL Biopharmaceuticals Sponsored ADR
―
Lyra Therapeutics
―
Bolt Biotherapeutics
―
Silexion Therapeutics
―
Acurx Pharmaceuticals
―
Ownership Overview
4.03% Insiders
0.95% Mutual Funds
0.16% Other Institutional Investors
94.46% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---